The following drug has potent antiandrogenic and weak progestational activity:

Questions 172

ATI RN

ATI RN Test Bank

Chapter 14 Drugs for the Reproductive System Questions

Question 1 of 5

The following drug has potent antiandrogenic and weak progestational activity:

Correct Answer: C

Rationale: The correct answer is C: Cyproterone acetate. Cyproterone acetate is a potent antiandrogen due to its ability to competitively block androgen receptors. It also exhibits weak progestational activity, making it effective in treating conditions like hirsutism and acne. Ethylestrenol (A) is an anabolic steroid, Clomiphene citrate (B) is a selective estrogen receptor modulator, and Magestrol acetate (D) is a progestin with no antiandrogenic properties.

Question 2 of 5

Transdermal estradiol differs from oral estrogen therapy in that it:

Correct Answer: D

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Question 3 of 5

The estrogen commonly used for hormone replacement therapy in menopausal women is:

Correct Answer: D

Rationale: The correct answer is D: Conjugated estrogens. Conjugated estrogens are derived from the urine of pregnant mares and contain a mixture of estrogens like estrone and equilin. They are commonly used for hormone replacement therapy in menopausal women due to their effectiveness in relieving menopausal symptoms. A: Ethinylestradiol is a synthetic estrogen commonly used in birth control pills, not as hormone replacement therapy in menopausal women. B: Estradiol benzoate is a form of estradiol used in veterinary medicine, not typically used in hormone replacement therapy for menopausal women. C: Diethylstilbestrol is a synthetic nonsteroidal estrogen that has been largely discontinued due to its association with serious health risks, not commonly used for hormone replacement therapy in menopausal women.

Question 4 of 5

The drug/drugs that can be used to treat osteoporosis is/are:

Correct Answer: D

Rationale: The correct answer is D because both Raloxifene (a selective estrogen receptor modulator) and Alendronate (a bisphosphonate) are commonly used to treat osteoporosis. Raloxifene helps prevent bone loss and reduces fracture risk, while Alendronate slows down bone breakdown. Pamidronate (choice C) is not typically used for osteoporosis treatment. Therefore, choices A, B, and C are incorrect.

Question 5 of 5

The most suitable vitamin D preparation for vitamin D dependent rickets is:

Correct Answer: D

Rationale: The correct answer is D: Calcitriol. Calcitriol is the active form of vitamin D and is the most suitable preparation for vitamin D dependent rickets as it directly increases calcium absorption in the intestines and promotes bone mineralization. Calcitriol is essential for regulating calcium and phosphorus levels in the body. Choice A, Calciferol, is a general term for vitamin D compounds and is not specific enough for rickets treatment. Choice B, Cholecalciferol, is the precursor form of vitamin D and needs to be converted to calcitriol in the body. Choice C, Calcifediol, is an intermediate form that also requires conversion to calcitriol for biological activity. Therefore, calcitriol is the most appropriate choice for treating vitamin D dependent rickets due to its direct action on calcium metabolism and bone health.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions